Target intelligence / Profile preview

Prion-like protein doppel (PRND)

Target
PRND
Molecular classification
GPI-anchored protein, Glycoprotein, Other
01

Overview

Prion-like protein doppel (PRND) is a membrane glycosylphosphatidylinositol (GPI)-anchored glycoprotein with significant structural similarity to the cellular prion protein (PrPC), sharing about 25% sequence identity in key regions[1][3]. The PRND gene is located on chromosome 20 in humans, close to the prion protein gene (PRNP)[3][5]. Unlike PrPC, PRND (Doppel) is predominantly expressed in the testis and is required for normal acrosome function and male fertility, with much lower expression in the adult central nervous system[1][3][5]. It is not involved in the propagation of misfolded prion protein associated with transmissible spongiform encephalopathies, but its role in neurodegenerative disease remains under investigation, as animal studies have linked doppel overexpression in the brain to neurodegeneration[1][5]. Mutations in PRND may be associated with neurodegenerative disease risk, but evidence in humans is contradictory and does not establish a clear causal link[1][5]. No drugs are currently known to target PRND directly, and it is not considered a therapeutic target at this time.

Other names
Prion protein 2 (dublet)Doppel proteinDPLDOPPELPrPLPUNQ1830/PRO3443dJ1068H6.4downstream prion protein-like geneprion gene complex, downstreamprion protein 2
02

Biological functions

Acrosome reactionMale fertilityCopper ion bindingRegulation of gametogenesis
03

Disease associations

Neurodegenerative diseaseOther
04

Safety considerations

Low expression in central nervous system in adults; Overexpression in CNS implicated in neurodegenerative pathology in animal models[1]

Beyond the preview

Go deeper on Prion-like protein doppel (PRND).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prion-like protein doppel (PRND).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call